MedTrace Logo

Cancer Center Trials: Reasons for Low Accrual Rates at One Academic Institution Vs. The Community Setting

NCT00322647 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2010-01-07

No results posted yet for this study

Summary

1. To identify reasons for low patient recruitment numbers to clinical trials in a cancer research center setting (and a community setting) in order to attempt to increase accrual rates.
2. To review the screening sheet for women who considered participating in the study of Tamoxifen and Raloxifene (STAR) for the prevention of breast cancer in high risk women through the University of New Mexico in Albuquerque from 1999 through 2004

Conditions

Sponsors & Collaborators

  • University of New Mexico

    lead OTHER

Principal Investigators

  • Claire Verschraegen, MD · University of New Mexico

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00322647 on ClinicalTrials.gov